- Home
- BHR vs TLSI Comparison
BHR vs TLSI Comparison
Compare BHR & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHR
- TLSI
- Stock Information
- Founded
- BHR 2013
- TLSI 2010
- Country
- BHR United States
- TLSI United States
- Employees
- BHR N/A
- TLSI N/A
- Industry
- BHR Real Estate Investment Trusts
- TLSI Medical Specialities
- Sector
- BHR Real Estate
- TLSI Health Care
- Exchange
- BHR Nasdaq
- TLSI Nasdaq
- Market Cap
- BHR 171.0M
- TLSI 204.0M
- IPO Year
- BHR N/A
- TLSI N/A
- Fundamental
- Price
- BHR $2.51
- TLSI $5.43
- Analyst Decision
- BHR
- TLSI Strong Buy
- Analyst Count
- BHR 0
- TLSI 5
- Target Price
- BHR N/A
- TLSI $10.90
- AVG Volume (30 Days)
- BHR 332.6K
- TLSI 146.8K
- Earning Date
- BHR 07-31-2025
- TLSI 08-13-2025
- Dividend Yield
- BHR 8.05%
- TLSI N/A
- EPS Growth
- BHR N/A
- TLSI N/A
- EPS
- BHR N/A
- TLSI N/A
- Revenue
- BHR $723,586,000.00
- TLSI $32,141,000.00
- Revenue This Year
- BHR N/A
- TLSI $55.52
- Revenue Next Year
- BHR $2.32
- TLSI $54.76
- P/E Ratio
- BHR N/A
- TLSI N/A
- Revenue Growth
- BHR N/A
- TLSI 46.20
- 52 Week Low
- BHR $1.80
- TLSI $3.50
- 52 Week High
- BHR $3.95
- TLSI $6.04
- Technical
- Relative Strength Index (RSI)
- BHR 65.05
- TLSI 50.01
- Support Level
- BHR $2.41
- TLSI $5.18
- Resistance Level
- BHR $2.62
- TLSI $5.65
- Average True Range (ATR)
- BHR 0.13
- TLSI 0.35
- MACD
- BHR 0.01
- TLSI -0.02
- Stochastic Oscillator
- BHR 86.90
- TLSI 49.23
About BHR Braemar Hotels & Resorts Inc.
Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury, upper-upscale and upscale hotels in gateway and resort locations. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment of the hotel lodging industry. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and, among others.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.